Literature DB >> 10994366

[Radiotherapy in Langerhans-cell histiocytosis. 2 case reports and review of the literature].

R Heyd1, G Strassmann, F Donnerstag, T Martin, N Zamboglou.   

Abstract

The use of radiotherapy in the treatment of Langerhans' cell histiocytosis was first reported in the literature in 1930 and has been proven as effective in numerous studies. We present the results of two female adults with eosinophilic granuloma of bone who underwent conventionally fractionated radiation therapy with total doses of 7 x 1.8 Gy and 7 x 2.0 Gy in four different sites. After observation periods raging from three months to six years local control of the disease was achieved in all treated locations. A review of 18 previously published studies include a total of 310 sites of eosinophilic granuloma of bone in 216 patients. It was demonstrated in 13 studies that the patients had complete relief of symptoms. An average of 94.3% had local control of the symptoms. Furthermore, in 12 studies for a total of 344 cases with involvement of other organs local control was reported in an average of 64.8% (range: 14.3-100%). Based on our own observations and on the literature review we conclude that low dose radiation therapy plays an important role in the management of localised Langerhans' cell histiocytosis. In order to minimise the risk of radiation induced neoplasms an accurate and precise radiation technique is required.

Entities:  

Mesh:

Year:  2000        PMID: 10994366

Source DB:  PubMed          Journal:  Rontgenpraxis        ISSN: 0035-7820


  7 in total

1.  Does adjunctive chemotherapy reduce remission rates compared to cortisone alone in unifocal or multifocal histiocytosis of bone?

Authors:  André Mathias Baptista; André Ferrari França Camargo; Olavo Pires de Camargo; Vicente Odone Filho; Alejandro Enzo Cassone
Journal:  Clin Orthop Relat Res       Date:  2012-03       Impact factor: 4.176

2.  Langerhans' cell histiocytosis of the temporal bone: A case report.

Authors:  Maomei Ni; Xiuhai Yang
Journal:  Exp Ther Med       Date:  2017-01-20       Impact factor: 2.447

3.  Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease.

Authors:  Jan Kriz; Hans Theodor Eich; Frank Bruns; Reinhard Heyd; Ulrich Schäfer; Uwe Haverkamp; Jens Büntzel; Heinrich Seegenschmiedt; Oliver Micke
Journal:  Radiat Oncol       Date:  2013-10-09       Impact factor: 3.481

4.  Langerhans cell histiocytosis of the cranial base: is low-dose radiotherapy effective?

Authors:  Andreas Meyer; Michael Stark; Johann H Karstens; Hans Christiansen; Frank Bruns
Journal:  Case Rep Oncol Med       Date:  2012-08-16

Review 5.  Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net.

Authors:  Michael Girschikofsky; Maurizio Arico; Diego Castillo; Anthony Chu; Claus Doberauer; Joachim Fichter; Julien Haroche; Gregory A Kaltsas; Polyzois Makras; Angelo V Marzano; Mathilde de Menthon; Oliver Micke; Emanuela Passoni; Heinrich M Seegenschmiedt; Abdellatif Tazi; Kenneth L McClain
Journal:  Orphanet J Rare Dis       Date:  2013-05-14       Impact factor: 4.123

6.  Radiotherapy for Langerhans Cell Histiocytosis of Bilateral Eyelids.

Authors:  James Leveson; Jean-Marc Bourque; Jelena Lukovic; A Rashid Dar
Journal:  Cureus       Date:  2016-02-02

Review 7.  Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment.

Authors:  Masayuki Kobayashi; Arinobu Tojo
Journal:  Cancer Sci       Date:  2018-10-30       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.